Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Frey

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Missouri Medicine|April 21, 2020
COVID-19 Teaches Hard LessonsJin Wang, Sharon Frey
Vaccine|September 25, 2003
Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adultsSharon Frey, Gregory Poland, Sandra Percell, et al.
Therapeutic Advances in Infectious Disease|January 19, 2018
Risk factors and outcomes for multidrug-resistant Gram-negative bacilli bacteremiaSwati Patolia, Getahun Abate, Nirav Patel, et al.
The American Journal of Medicine|December 6, 2006
A rod in the spineBassem T Chaar, Ganesh C Kudva, Sharon Frey, et al.
International Journal of Hygiene and Environmental Health|May 23, 2002
Future directions for EPA Superfund researchRandall S Wentsel, Ben Blaney, Lorelei Kowalski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2010
Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adultsSharon Frey, Timo Vesikari, Agnieszka Szymczakiewicz-Multanowska, et al.
NPJ Vaccines|January 30, 2020
Flagellin adjuvanted F1/V subunit plague vaccine induces T cell and functional antibody responses with unique gene signaturesFahreta Hamzabegovic, Johannes B Goll, William F Hooper, et al.
Vaccine|June 30, 2009
In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopesLeonard Moise, Julie A McMurry, Soren Buus, et al.
Vaccine|June 15, 2004
Long-term memory B-cell responses in recipients of candidate human immunodeficiency virus type 1 vaccinesThomas G Evans, Sharon Frey, Heidi Israel, et al.
Toxins|March 24, 2022
Determination of Cyanotoxins and Prymnesins in Water, Fish Tissue, and Other Matrices: A ReviewDevi Sundaravadivelu, Toby T Sanan, Raghuraman Venkatapathy, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Missouri Medicine|April 21, 2020
COVID-19 Teaches Hard LessonsJin Wang, Sharon Frey
Vaccine|September 25, 2003
Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adultsSharon Frey, Gregory Poland, Sandra Percell, et al.
Therapeutic Advances in Infectious Disease|January 19, 2018
Risk factors and outcomes for multidrug-resistant Gram-negative bacilli bacteremiaSwati Patolia, Getahun Abate, Nirav Patel, et al.
The American Journal of Medicine|December 6, 2006
A rod in the spineBassem T Chaar, Ganesh C Kudva, Sharon Frey, et al.
International Journal of Hygiene and Environmental Health|May 23, 2002
Future directions for EPA Superfund researchRandall S Wentsel, Ben Blaney, Lorelei Kowalski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2010
Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adultsSharon Frey, Timo Vesikari, Agnieszka Szymczakiewicz-Multanowska, et al.
NPJ Vaccines|January 30, 2020
Flagellin adjuvanted F1/V subunit plague vaccine induces T cell and functional antibody responses with unique gene signaturesFahreta Hamzabegovic, Johannes B Goll, William F Hooper, et al.
Vaccine|June 30, 2009
In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopesLeonard Moise, Julie A McMurry, Soren Buus, et al.
Vaccine|June 15, 2004
Long-term memory B-cell responses in recipients of candidate human immunodeficiency virus type 1 vaccinesThomas G Evans, Sharon Frey, Heidi Israel, et al.
Toxins|March 24, 2022
Determination of Cyanotoxins and Prymnesins in Water, Fish Tissue, and Other Matrices: A ReviewDevi Sundaravadivelu, Toby T Sanan, Raghuraman Venkatapathy, et al.
Pageof 3